IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics.

Diasome is preparing to advance its HDV-insulin formulation into pivotal studies after generating positive Phase IIb data in type 1 diabetes (T1D) earlier this year and presenting it at two ...

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies ...

Under the terms of the pharma deal, Enodia will screen, optimize, and develop Sec61 inhibitor candidates against multiple ...

Spatial technologies preserve tissue context to guide therapeutic development and translate molecular insights into ...

The list of tools includes SpliceA12, a new iteration of a genomic AI model designed to identify disease-relevant splice ...

Proteomic analysis identifies a 26-protein signature of continued ovarian remodeling across the decades following menopause.

Limiting expansion steps to three days could increase the proportion of naive T cells in, and speed up the production of, CAR T-cell therapies.

Multiomics analysis combines data from two or more omics layers—such as genomics, transcriptomics, proteomics, and ...

Strategic automation and flexible bioprocessing could help cell and gene therapies scale across diverse APAC markets.

Research shows that as biocatalysts, solvents can affect stereochemistry, thermostability, and other process parameters.

Results provide framework for uncovering regulatory variants in other X chromosome neurodevelopmental genes that may ...